Current List of Laboratories Which Meet Minimum Standards To Engage in Urine Drug Testing for Federal Agencies, 59356-59358 [05-20488]
Download as PDF
<![CDATA[
59356
Federal Register / Vol. 70, No. 196 / Wednesday, October 12, 2005 / Notices
(Catalogue of Federal Domestic Assistance
Program Nos. 93.855, Allergy, Immunology,
and Transplantation Research; 93.856,
Microbiology and Infectious Diseases
Research, National Institutes of Health, HHS)
Dated: October 3, 2005.
Anthony M. Coelho, Jr.,
Acting Director, Office of Federal Advisory
Committee Policy.
[FR Doc. 05–20431 Filed 10–11–05; 8:45 am]
BILLING CODE 4140–01–M
DEPARTMENT OF HEALTH AND
HUMAN SERVICES
NIDDK, National Institues of Health, Room
772, 6707 Democracy Boulevard, Bethesda,
MD 20892–5452, (301) 594–2242,
sahaia@extra.niddk.nih.gov.
(Catalogue of Federal Domestic Assistance
Program Nos. 93.847, Diabetes,
Endocrinology and Metabolic Research;
93.848, Digestive Diseases and Nutrition
Research; 93.849, Kidney Diseases, Urology
and Hematology Research, National Institutes
of Health, HHS)
Dated: October 02, 2005.
Anthony M. Coelho, Jr.,
Acting Director, Office of Federal Advisory
Committee Policy.
[FR Doc. 05–20432 Filed 10–11–05; 8:45am]
National Institutes of Health
BILLING CODE Code 4140–01–M
National Institute of Diabetes and
Digestive and Kidney Diseases; Notice
of Closed Meetings
DEPARTMENT OF HEALTH AND
HUMAN SERVICES
Pursuant to section 10(d) of the
Federal Advisory Committee Act, as
amended (5 U.S.C. Appendix 2), notice
is hereby given of the following
meetings.
The meetings will be closed to the
public in accordance with the
provisions set forth in sections
552b(c)(4) and 552(c)(6), Title 5 U.S.C.,
as amended. The grant applications and
the discussions could disclose
confidential trade secrets or commercial
property such as patentable material,
and personal information concerning
individuals associated with the grant
applications, the disclosure of which
would constitute a clearly unwarranted
invasion of personal privacy.
Name of Committee: National Institute of
Diabetes and Digestive and Kidney Diseases
Special Emphasis Panel. Research Training
in Pediatric Gastroenterology.
Date: October 26, 2005.
Time: 11 a.m. to 12 p.m.
Agenda: To review and evaluate grant
applications.
Place: National Institutes of Health, One
Democracy Plaza, 6701 Democracy
Boulevard, Bethesda, MD 20892, (Telephone
Conference Call).
Contact Person: Xiaodu Guo, MD, PhD,
Scientific Review Administrator, Review
Branch, DEA, NIDDK, National Institutes of
Health, Room 705, 6707 Democracy
Boulevard, Bethesda, MD 20892–5452, (301)
594–4719, guox@extra.niddk.nih.gov.
Name of Committee: National Institute of
Diabetes and Digestive and Kidney Diseases
Special Emphasis Panel. Sphincter of Oddi
Dysfunction.
Date: November 1, 2005.
Time: 1:30 p.m. to 3 p.m.
Agenda: To review and evaluate grant
applications.
Place: National Institutes of Health, Two
Democracy Plaza, 6707 Democracy
Boulevard, Bethesda, MD 20892, (Telephone
Conference Call).
Contact Person: Atul Sahai, PhD, Scientific
Review Administrator, Review Branch, DEA,
VerDate Aug<31>2005
19:48 Oct 11, 2005
Jkt 208001
National Institutes of Health
National Library of Medicine; Amended
Notice of Meeting
Notice is hereby given of a change in
the meeting of the Board of Scientific
Counselors, National Library of
Medicine, October 25, 2005, 9 a.m. to
October 25, 2005, 5 p.m., National
Library of Medicine, Building 38, Board
Room, 2nd Floor, 8600 Rockville Pike,
Bethesda, MD 20892 which was
published in the Federal Register on
August 16, 2005, 70 FR 48166.
In addition to the October 25, 2005
meeting, there will be a meeting on
October 24, 2005 from 5 p.m. to 7 p.m.
at the Bethesda Marriott, 5151 Pooks
Hill Road, Bethesda, Maryland 20892.
The meeting is partially closed to the
public.
Dated: October 3, 2005.
Anthony M. Coelho, Jr.,
Acting Director, Office of Federal Advisory
Committee Policy.
[FR Doc. 05–20430 Filed 10–11–05; 8:45 am]
BILLING CODE 4140–01–M
DEPARTMENT OF HEALTH AND
HUMAN SERVICES
Substance Abuse and Mental Health
Services Administration
Current List of Laboratories Which
Meet Minimum Standards To Engage in
Urine Drug Testing for Federal
Agencies
Substance Abuse and Mental
Health Services Administration, HHS.
ACTION: Notice.
AGENCY:
SUMMARY: The Department of Health and
Human Services (HHS) notifies Federal
agencies of the laboratories currently
PO 00000
Frm 00045
Fmt 4703
Sfmt 4703
certified to meet the standards of
Subpart C of the Mandatory Guidelines
for Federal Workplace Drug Testing
Programs (Mandatory Guidelines). The
Mandatory Guidelines were first
published in the Federal Register on
April 11, 1988 (53 FR 11970), and
subsequently revised in the Federal
Register on June 9, 1994 (59 FR 29908),
on September 30, 1997 (62 FR 51118),
and on April 13, 2004 (69 FR 19644).
A notice listing all currently certified
laboratories is published in the Federal
Register during the first week of each
month. If any laboratory’s certification
is suspended or revoked, the laboratory
will be omitted from subsequent lists
until such time as it is restored to full
certification under the Mandatory
Guidelines.
If any laboratory has withdrawn from
the HHS National Laboratory
Certification Program (NLCP) during the
past month, it will be listed at the end,
and will be omitted from the monthly
listing thereafter.
This notice is also available on the
Internet at https://workplace.samhsa.gov
and https://www.drugfreeworkplace.gov.
FOR FURTHER INFORMATION CONTACT: Mrs.
Giselle Hersh or Dr. Walter Vogl,
Division of Workplace Programs,
SAMHSA/CSAP, Room 2–1035, 1 Choke
Cherry Road, Rockville, Maryland
20857; (240) 276–2600 (voice), (240)
276–2610 (fax).
SUPPLEMENTARY INFORMATION: The
Mandatory Guidelines were developed
in accordance with Executive Order
12564 and section 503 of Public Law
100–71. Subpart C of the Mandatory
Guidelines, ‘‘Certification of
Laboratories Engaged in Urine Drug
Testing for Federal Agencies,’’ sets strict
standards that laboratories must meet in
order to conduct drug and specimen
validity tests on urine specimens for
Federal agencies. To become certified,
an applicant laboratory must undergo
three rounds of performance testing plus
an on-site inspection. To maintain that
certification, a laboratory must
participate in a quarterly performance
testing program plus undergo periodic,
on-site inspections.
Laboratories which claim to be in the
applicant stage of certification are not to
be considered as meeting the minimum
requirements described in the HHS
Mandatory Guidelines. A laboratory
must have its letter of certification from
HHS/SAMHSA (formerly: HHS/NIDA)
which attests that it has met minimum
standards.
In accordance with Subpart C of the
Mandatory Guidelines dated April 13,
2004 (69 FR 19644), the following
laboratories meet the minimum
E:\FR\FM\12OCN1.SGM
12OCN1
Federal Register / Vol. 70, No. 196 / Wednesday, October 12, 2005 / Notices
standards to conduct drug and specimen
validity tests on urine specimens:
ACL Laboratories
8901 W. Lincoln Ave.
West Allis, WI 53227
414–328–7840/800–877–7016
(Formerly: Bayshore Clinical
Laboratory).
ACM Medical Laboratory, Inc.
160 Elmgrove Park
Rochester, NY 14624
585–429–2264.
Advanced Toxicology Network
3560 Air Center Cove, Suite 101
Memphis, TN 38118
901–794–5770/888–290–1150.
Aegis Analytical Laboratories, Inc.
345 Hill Ave.
Nashville, TN 37210
615–255–2400.
Baptist Medical Center-Toxicology
Laboratory
9601 I–630, Exit 7
Little Rock, AR 72205–7299
501–202–2783
(Formerly: Forensic Toxicology
Laboratory Baptist Medical Center).
Clinical Reference Lab
8433 Quivira Road
Lenexa, KS 66215–2802
800–445–6917.
Diagnostic Services, Inc., dba DSI
12700 Westlinks Drive
Fort Myers, FL 33913
239–561–8200/800–735–5416.
Doctors Laboratory, Inc.
2906 Julia Drive
Valdosta, GA 31602
229–671–2281.
DrugScan, Inc.
P.O. Box 2969
1119 Mearns Road
Warminster, PA 18974
215–674–9310.
Dynacare Kasper Medical Laboratories*
10150–102 St., Suite 200
Edmonton, Alberta
Canada T5J 5E2
780–451–3702/800–661–9876.
ElSohly Laboratories, Inc.
5 Industrial Park Drive
Oxford, MS 38655
662–236–2609.
Express Analytical Labs
3405 7th Ave., Suite 106
Marion, IA 52302
319–377–0500.
Gamma-Dynacare Medical Laboratories*
A Division of the Gamma-Dynacare
Laboratory Partnership
245 Pall Mall Street
London, ONT, Canada N6A 1P4
519–679–1630.
General Medical Laboratories
36 South Brooks St.
Madison, WI 53715
VerDate Aug<31>2005
19:48 Oct 11, 2005
Jkt 208001
608–267–6225.
LabOne, Inc.
10101 Renner Blvd.
Lenexa, KS 66219
913–888–3927/800–873–8845
(Formerly: Center for Laboratory
Services, a Division of LabOne, Inc.).
Laboratory Corporation of America
Holdings
7207 N. Gessner Road
Houston, TX 77040
713–856–8288/800–800–2387.
Laboratory Corporation of America
Holdings
69 First Ave.
Raritan, NJ 08869
908–526–2400/800–437–4986
(Formerly: Roche Biomedical
Laboratories, Inc.).
Laboratory Corporation of America
Holdings
1904 Alexander Drive
Research Triangle Park, NC 27709
919–572–6900/800–833–3984
(Formerly: LabCorp Occupational
Testing Services, Inc., CompuChem
Laboratories, Inc.; CompuChem
Laboratories, Inc., A Subsidiary of
Roche Biomedical Laboratory; Roche
CompuChem Laboratories, Inc., A
Member of the Roche Group).
Laboratory Corporation of America
Holdings
10788 Roselle St.
San Diego, CA 92121
800–882–7272
(Formerly: Poisonlab, Inc.).
Laboratory Corporation of America
Holdings
550 17th Ave., Suite 300
Seattle, WA 98122
206–923–7020 / 800–898–0180
(Formerly: DrugProof, Division of
Dynacare/Laboratory of Pathology,
LLC; Laboratory of Pathology of
Seattle, Inc.; DrugProof, Division of
Laboratory of Pathology of Seattle,
Inc.).
Laboratory Corporation of America
Holdings
1120 Main Street
Southaven, MS 38671
866–827–8042 / 800–233–6339
(Formerly: LabCorp Occupational
Testing Services, Inc.; MedExpress/
National Laboratory Center).
Marshfield Laboratories
Forensic Toxicology Laboratory
1000 North Oak Ave.
Marshfield, WI 54449
715–389–3734 / 800–331–3734.
MAXXAM Analytics Inc.*
6740 Campobello Road
Mississauga, ON
Canada L5N 2L8
905–817–5700
(Formerly: NOVAMANN (Ontario),
Inc.).
PO 00000
Frm 00046
Fmt 4703
Sfmt 4703
59357
MedTox Laboratories, Inc.
402 W. County Road D
St. Paul, MN 55112
651–636–7466 / 800–832–3244.
MetroLab-Legacy Laboratory Services
1225 NE 2nd Ave.
Portland, OR 97232
503–413–5295 / 800–950–5295.
Minneapolis Veterans Affairs Medical
Center
Forensic Toxicology Laboratory
1 Veterans Drive
Minneapolis, MN 55417
612–725–2088.
National Toxicology Laboratories, Inc.
1100 California Ave.
Bakersfield, CA 93304
661–322–4250 / 800–350–3515.
Northwest Toxicology, a LabOne
Company
2282 South Presidents Drive, Suite C
West Valley City, UT 84120
801–606–6301 / 800–322–3361
(Formerly: LabOne, Inc., dba Northwest
Toxicology; NWT Drug Testing,
NorthWest Toxicology, Inc.;
Northwest Drug Testing, a division of
NWT Inc.).
One Source Toxicology Laboratory, Inc.
1213 Genoa-Red Bluff
Pasadena, TX 77504
888–747–3774
(Formerly: University of Texas Medical
Branch, Clinical Chemistry Division;
UTMB Pathology-Toxicology
Laboratory).
Oregon Medical Laboratories
P.O. Box 972
722 East 11th Ave.
Eugene, OR 97440–0972
541–687–2134.
Pacific Toxicology Laboratories
9348 DeSoto Ave.
Chatsworth, CA 91311
800–328–6942
(Formerly: Centinela Hospital Airport
Toxicology Laboratory).
Pathology Associates Medical
Laboratories
110 West Cliff Dr.
Spokane, WA 99204
509–755–8991 / 800–541–7897x7.
Physicians Reference Laboratory
7800 West 110th St.
Overland Park, KS 66210
913–339–0372 / 800–821–3627.
Quest Diagnostics Incorporated
3175 Presidential Dr.
Atlanta, GA 30340
770–452–1590 / 800–729–6432
(Formerly: SmithKline Beecham
Clinical Laboratories; SmithKline BioScience Laboratories).
Quest Diagnostics Incorporated
4770 Regent Blvd.
Irving, TX 75063
E:\FR\FM\12OCN1.SGM
12OCN1
59358
Federal Register / Vol. 70, No. 196 / Wednesday, October 12, 2005 / Notices
800–824–6152
(Moved from the Dallas location on
03/31/01; Formerly: SmithKline
Beecham Clinical Laboratories;
SmithKline Bio-Science Laboratories).
Quest Diagnostics Incorporated
4230 South Burnham Ave., Suite 250
Las Vegas, NV 89119–5412
702–733–7866 / 800–433–2750
(Formerly: Associated Pathologists
Laboratories, Inc.).
Quest Diagnostics Incorporated
400 Egypt Road
Norristown, PA 19403
610–631–4600 / 877–642–2216
(Formerly: SmithKline Beecham
Clinical Laboratories; SmithKline BioScience Laboratories).
Quest Diagnostics Incorporated
506 E. State Pkwy.
Schaumburg, IL 60173
800–669–6995 / 847–885–2010
(Formerly: SmithKline Beecham
Clinical Laboratories; International
Toxicology Laboratories).
Quest Diagnostics Incorporated
7600 Tyrone Ave.
Van Nuys, CA 91405
818–989–2520 / 800–877–2520
(Formerly: SmithKline Beecham
Clinical Laboratories).
Scientific Testing Laboratories, Inc.
450 Southlake Blvd.
Richmond, VA 23236
804–378–9130.
Sciteck Clinical Laboratories, Inc.
317 Rutledge Road
Fletcher, NC 28732
828–650–0409
S.E.D. Medical Laboratories
5601 Office Blvd.
Albuquerque, NM 87109
505–727–6300 / 800–999–5227.
South Bend Medical Foundation, Inc.
530 N. Lafayette Blvd.
South Bend, IN 46601
574–234–4176 x276.
Southwest Laboratories
4645 E. Cotton Center Boulevard
Suite 177
Phoenix, AZ 85040
602–438–8507 / 800–279–0027.
Sparrow Health System
Toxicology Testing Center, St. Lawrence
Campus
1210 W. Saginaw
Lansing, MI 48915
517–364–7400
(Formerly: St. Lawrence Hospital &
Healthcare System).
St. Anthony Hospital Toxicology
Laboratory
1000 N. Lee St.
Oklahoma City, OK 73101
405–272–7052.
Toxicology & Drug Monitoring
Laboratory
University of Missouri Hospital &
Clinics
301 Business Loop 70 West, Suite 208
Columbia, MO 65203
573–882–1273.
Toxicology Testing Service, Inc.
5426 N.W. 79th Ave.
Miami, FL 33166
305–593–2260.
US Army Forensic Toxicology Drug
Testing Laboratory
2490 Wilson St.
Fort George G. Meade, MD 20755–5235
301–677–7085.
As a result of hurricane Katrina, the
following laboratory’s certification is
suspended because extensive damage to
the New Orleans area has prevented the
laboratory from testing specimens and
fully participating in the National
Laboratory Certification Program:
Kroll Laboratory Specialists, Inc.
1111 Newton St.
Gretna, LA 70053
504–361–8989 / 800–433–3823
(Formerly: Laboratory Specialists, Inc.).
* The Standards Council of Canada (SCC) voted
to end its Laboratory Accreditation Program for
Substance Abuse (LAPSA) effective May 12, 1998.
Laboratories certified through that program were
accredited to conduct forensic urine drug testing as
required by U.S. Department of Transportation
(DOT) regulations. As of that date, the certification
of those accredited Canadian laboratories will
continue under DOT authority. The responsibility
for conducting quarterly performance testing plus
periodic on-site inspections of those LAPSAaccredited laboratories was transferred to the U.S.
HHS, with the HHS’ NLCP contractor continuing to
have an active role in the performance testing and
laboratory inspection processes. Other Canadian
laboratories wishing to be considered for the NLCP
may apply directly to the NLCP contractor just as
U.S. laboratories do.
Upon finding a Canadian laboratory to be
qualified, HHS will recommend that DOT certify
VerDate Aug<31>2005
19:48 Oct 11, 2005
Jkt 208001
Anna Marsh,
Director, Office Program Services, SAMHSA.
[FR Doc. 05–20488 Filed 10–11–05; 8:45 am]
BILLING CODE 4160–20–U
DEPARTMENT OF HOMELAND
SECURITY
Federal Emergency Management
Agency
Agency Information Collection
Activities: Proposed Collection;
Comment Request
Federal Emergency
Management Agency, Emergency
Preparedness and Response Directorate,
U.S. Department of Homeland Security.
ACTION: Notice and request for
comments.
AGENCY:
PO 00000
Frm 00047
Fmt 4703
Sfmt 4703
SUMMARY: The Federal Emergency
Management Agency, as part of its
continuing effort to reduce paperwork
and respondent burden, invites the
general public and other Federal
agencies to take this opportunity to
comment on proposed continuing
information collections. In accordance
with the Paperwork Reduction Act of
1995 (44 U.S.C. 3506(c)(2)(A)), this
notice seeks comments concerning the
application for participation in the
National Flood Insurance Program
(NFIP).
The NFIP
is authorized by Public Law 90–448
(1968) and expanded by Public Law 93–
234 (1973). Communities must make
application for eligibility in the program
by submitting the items listed on the
enclosed ‘‘prerequisites for the sale of
flood insurance’’ which is taken from
section 59.22 CFR 44 of the NFIP
regulations. Section 201 of the Flood
Disaster Protection Act of 1973 requires
all flood-prone communities throughout
the country to apply for participation
one year after their flood prone
identification or submit to the
prohibition of certain types of Federal
and Federally-related financial
assistance for use in their floodplains.
SUPPLEMENTARY INFORMATION:
Collection of Information
Title: Application for Participation in
the National Flood Insurance Program.
Type of Information Collection:
Reinstatement.
OMB Number: 1660–0004.
Form Numbers: FEMA Form 81–64.
Abstract: The NFIP provides flood
insurance to communities that apply for
participation and make a commitment
to adopt and enforce land use control
measures that are designed to protect
development from future flood damages.
The application form will enable FEMA
to continue to rapidly process new
community applications and to thereby
more quickly provide flood insurance
protection to the residents of the
communities. Participation in the NFIP
is mandatory in order for flood related
Presidentially-declared communities to
receive Federal disaster assistance.
Affected Public: State, Local or Tribal
Governments.
Estimated Total Annual Burden
Hours: 600 hours.
the laboratory (Federal Register, July 16, 1996) as
meeting the minimum standards of the Mandatory
Guidelines published in the Federal Register on
April 13, 2004 (69 FR 19644). After receiving DOT
certification, the laboratory will be included in the
monthly list of HHS-certified laboratories and
participate in the NLCP certification maintenance
program.
E:\FR\FM\12OCN1.SGM
12OCN1
]]>Agencies
[Federal Register Volume 70, Number 196 (Wednesday, October 12, 2005)]
[Notices]
[Pages 59356-59358]
From the Federal Register Online via the Government Printing Office [www.gpo.gov]
[FR Doc No: 05-20488]
-----------------------------------------------------------------------
DEPARTMENT OF HEALTH AND HUMAN SERVICES
Substance Abuse and Mental Health Services Administration
Current List of Laboratories Which Meet Minimum Standards To
Engage in Urine Drug Testing for Federal Agencies
AGENCY: Substance Abuse and Mental Health Services Administration, HHS.
ACTION: Notice.
-----------------------------------------------------------------------
SUMMARY: The Department of Health and Human Services (HHS) notifies
Federal agencies of the laboratories currently certified to meet the
standards of Subpart C of the Mandatory Guidelines for Federal
Workplace Drug Testing Programs (Mandatory Guidelines). The Mandatory
Guidelines were first published in the Federal Register on April 11,
1988 (53 FR 11970), and subsequently revised in the Federal Register on
June 9, 1994 (59 FR 29908), on September 30, 1997 (62 FR 51118), and on
April 13, 2004 (69 FR 19644).
A notice listing all currently certified laboratories is published
in the Federal Register during the first week of each month. If any
laboratory's certification is suspended or revoked, the laboratory will
be omitted from subsequent lists until such time as it is restored to
full certification under the Mandatory Guidelines.
If any laboratory has withdrawn from the HHS National Laboratory
Certification Program (NLCP) during the past month, it will be listed
at the end, and will be omitted from the monthly listing thereafter.
This notice is also available on the Internet at https://
workplace.samhsa.gov and https://www.drugfreeworkplace.gov.
FOR FURTHER INFORMATION CONTACT: Mrs. Giselle Hersh or Dr. Walter Vogl,
Division of Workplace Programs, SAMHSA/CSAP, Room 2-1035, 1 Choke
Cherry Road, Rockville, Maryland 20857; (240) 276-2600 (voice), (240)
276-2610 (fax).
SUPPLEMENTARY INFORMATION: The Mandatory Guidelines were developed in
accordance with Executive Order 12564 and section 503 of Public Law
100-71. Subpart C of the Mandatory Guidelines, ``Certification of
Laboratories Engaged in Urine Drug Testing for Federal Agencies,'' sets
strict standards that laboratories must meet in order to conduct drug
and specimen validity tests on urine specimens for Federal agencies. To
become certified, an applicant laboratory must undergo three rounds of
performance testing plus an on-site inspection. To maintain that
certification, a laboratory must participate in a quarterly performance
testing program plus undergo periodic, on-site inspections.
Laboratories which claim to be in the applicant stage of
certification are not to be considered as meeting the minimum
requirements described in the HHS Mandatory Guidelines. A laboratory
must have its letter of certification from HHS/SAMHSA (formerly: HHS/
NIDA) which attests that it has met minimum standards.
In accordance with Subpart C of the Mandatory Guidelines dated
April 13, 2004 (69 FR 19644), the following laboratories meet the
minimum
[[Page 59357]]
standards to conduct drug and specimen validity tests on urine
specimens:
ACL Laboratories
8901 W. Lincoln Ave.
West Allis, WI 53227
414-328-7840/800-877-7016
(Formerly: Bayshore Clinical Laboratory).
ACM Medical Laboratory, Inc.
160 Elmgrove Park
Rochester, NY 14624
585-429-2264.
Advanced Toxicology Network
3560 Air Center Cove, Suite 101
Memphis, TN 38118
901-794-5770/888-290-1150.
Aegis Analytical Laboratories, Inc.
345 Hill Ave.
Nashville, TN 37210
615-255-2400.
Baptist Medical Center-Toxicology Laboratory
9601 I-630, Exit 7
Little Rock, AR 72205-7299
501-202-2783
(Formerly: Forensic Toxicology Laboratory Baptist Medical Center).
Clinical Reference Lab
8433 Quivira Road
Lenexa, KS 66215-2802
800-445-6917.
Diagnostic Services, Inc., dba DSI
12700 Westlinks Drive
Fort Myers, FL 33913
239-561-8200/800-735-5416.
Doctors Laboratory, Inc.
2906 Julia Drive
Valdosta, GA 31602
229-671-2281.
DrugScan, Inc.
P.O. Box 2969
1119 Mearns Road
Warminster, PA 18974
215-674-9310.
Dynacare Kasper Medical Laboratories*
10150-102 St., Suite 200
Edmonton, Alberta
Canada T5J 5E2
780-451-3702/800-661-9876.
ElSohly Laboratories, Inc.
5 Industrial Park Drive
Oxford, MS 38655
662-236-2609.
Express Analytical Labs
3405 7th Ave., Suite 106
Marion, IA 52302
319-377-0500.
Gamma-Dynacare Medical Laboratories*
A Division of the Gamma-Dynacare
Laboratory Partnership
245 Pall Mall Street
London, ONT, Canada N6A 1P4
519-679-1630.
General Medical Laboratories
36 South Brooks St.
Madison, WI 53715
608-267-6225.
LabOne, Inc.
10101 Renner Blvd.
Lenexa, KS 66219
913-888-3927/800-873-8845
(Formerly: Center for Laboratory Services, a Division of LabOne, Inc.).
Laboratory Corporation of America Holdings
7207 N. Gessner Road
Houston, TX 77040
713-856-8288/800-800-2387.
Laboratory Corporation of America Holdings
69 First Ave.
Raritan, NJ 08869
908-526-2400/800-437-4986
(Formerly: Roche Biomedical Laboratories, Inc.).
Laboratory Corporation of America Holdings
1904 Alexander Drive
Research Triangle Park, NC 27709
919-572-6900/800-833-3984
(Formerly: LabCorp Occupational Testing Services, Inc., CompuChem
Laboratories, Inc.; CompuChem Laboratories, Inc., A Subsidiary of Roche
Biomedical Laboratory; Roche CompuChem Laboratories, Inc., A Member of
the Roche Group).
Laboratory Corporation of America Holdings
10788 Roselle St.
San Diego, CA 92121
800-882-7272
(Formerly: Poisonlab, Inc.).
Laboratory Corporation of America Holdings
550 17th Ave., Suite 300
Seattle, WA 98122
206-923-7020 / 800-898-0180
(Formerly: DrugProof, Division of Dynacare/Laboratory of Pathology,
LLC; Laboratory of Pathology of Seattle, Inc.; DrugProof, Division of
Laboratory of Pathology of Seattle, Inc.).
Laboratory Corporation of America Holdings
1120 Main Street
Southaven, MS 38671
866-827-8042 / 800-233-6339
(Formerly: LabCorp Occupational Testing Services, Inc.; MedExpress/
National Laboratory Center).
Marshfield Laboratories
Forensic Toxicology Laboratory
1000 North Oak Ave.
Marshfield, WI 54449
715-389-3734 / 800-331-3734.
MAXXAM Analytics Inc.*
6740 Campobello Road
Mississauga, ON
Canada L5N 2L8
905-817-5700
(Formerly: NOVAMANN (Ontario), Inc.).
MedTox Laboratories, Inc.
402 W. County Road D
St. Paul, MN 55112
651-636-7466 / 800-832-3244.
MetroLab-Legacy Laboratory Services
1225 NE 2nd Ave.
Portland, OR 97232
503-413-5295 / 800-950-5295.
Minneapolis Veterans Affairs Medical Center
Forensic Toxicology Laboratory
1 Veterans Drive
Minneapolis, MN 55417
612-725-2088.
National Toxicology Laboratories, Inc.
1100 California Ave.
Bakersfield, CA 93304
661-322-4250 / 800-350-3515.
Northwest Toxicology, a LabOne Company
2282 South Presidents Drive, Suite C
West Valley City, UT 84120
801-606-6301 / 800-322-3361
(Formerly: LabOne, Inc., dba Northwest Toxicology; NWT Drug Testing,
NorthWest Toxicology, Inc.; Northwest Drug Testing, a division of NWT
Inc.).
One Source Toxicology Laboratory, Inc.
1213 Genoa-Red Bluff
Pasadena, TX 77504
888-747-3774
(Formerly: University of Texas Medical Branch, Clinical Chemistry
Division; UTMB Pathology-Toxicology Laboratory).
Oregon Medical Laboratories
P.O. Box 972
722 East 11th Ave.
Eugene, OR 97440-0972
541-687-2134.
Pacific Toxicology Laboratories
9348 DeSoto Ave.
Chatsworth, CA 91311
800-328-6942
(Formerly: Centinela Hospital Airport Toxicology Laboratory).
Pathology Associates Medical Laboratories
110 West Cliff Dr.
Spokane, WA 99204
509-755-8991 / 800-541-7897x7.
Physicians Reference Laboratory
7800 West 110th St.
Overland Park, KS 66210
913-339-0372 / 800-821-3627.
Quest Diagnostics Incorporated
3175 Presidential Dr.
Atlanta, GA 30340
770-452-1590 / 800-729-6432
(Formerly: SmithKline Beecham Clinical Laboratories; SmithKline Bio-
Science Laboratories).
Quest Diagnostics Incorporated
4770 Regent Blvd.
Irving, TX 75063
[[Page 59358]]
800-824-6152
(Moved from the Dallas location on 03/31/01; Formerly: SmithKline
Beecham Clinical Laboratories; SmithKline Bio-Science Laboratories).
Quest Diagnostics Incorporated
4230 South Burnham Ave., Suite 250
Las Vegas, NV 89119-5412
702-733-7866 / 800-433-2750
(Formerly: Associated Pathologists Laboratories, Inc.).
Quest Diagnostics Incorporated
400 Egypt Road
Norristown, PA 19403
610-631-4600 / 877-642-2216
(Formerly: SmithKline Beecham Clinical Laboratories; SmithKline Bio-
Science Laboratories).
Quest Diagnostics Incorporated
506 E. State Pkwy.
Schaumburg, IL 60173
800-669-6995 / 847-885-2010
(Formerly: SmithKline Beecham Clinical Laboratories; International
Toxicology Laboratories).
Quest Diagnostics Incorporated
7600 Tyrone Ave.
Van Nuys, CA 91405
818-989-2520 / 800-877-2520
(Formerly: SmithKline Beecham Clinical Laboratories).
Scientific Testing Laboratories, Inc.
450 Southlake Blvd.
Richmond, VA 23236
804-378-9130.
Sciteck Clinical Laboratories, Inc.
317 Rutledge Road
Fletcher, NC 28732
828-650-0409
S.E.D. Medical Laboratories
5601 Office Blvd.
Albuquerque, NM 87109
505-727-6300 / 800-999-5227.
South Bend Medical Foundation, Inc.
530 N. Lafayette Blvd.
South Bend, IN 46601
574-234-4176 x276.
Southwest Laboratories
4645 E. Cotton Center Boulevard
Suite 177
Phoenix, AZ 85040
602-438-8507 / 800-279-0027.
Sparrow Health System
Toxicology Testing Center, St. Lawrence Campus
1210 W. Saginaw
Lansing, MI 48915
517-364-7400
(Formerly: St. Lawrence Hospital & Healthcare System).
St. Anthony Hospital Toxicology Laboratory
1000 N. Lee St.
Oklahoma City, OK 73101
405-272-7052.
Toxicology & Drug Monitoring Laboratory
University of Missouri Hospital & Clinics
301 Business Loop 70 West, Suite 208
Columbia, MO 65203
573-882-1273.
Toxicology Testing Service, Inc.
5426 N.W. 79th Ave.
Miami, FL 33166
305-593-2260.
US Army Forensic Toxicology Drug Testing Laboratory
2490 Wilson St.
Fort George G. Meade, MD 20755-5235
301-677-7085.
As a result of hurricane Katrina, the following laboratory's
certification is suspended because extensive damage to the New Orleans
area has prevented the laboratory from testing specimens and fully
participating in the National Laboratory Certification Program:
Kroll Laboratory Specialists, Inc.
1111 Newton St.
Gretna, LA 70053
504-361-8989 / 800-433-3823
(Formerly: Laboratory Specialists, Inc.).
---------------------------------------------------------------------------
* The Standards Council of Canada (SCC) voted to end its
Laboratory Accreditation Program for Substance Abuse (LAPSA)
effective May 12, 1998. Laboratories certified through that program
were accredited to conduct forensic urine drug testing as required
by U.S. Department of Transportation (DOT) regulations. As of that
date, the certification of those accredited Canadian laboratories
will continue under DOT authority. The responsibility for conducting
quarterly performance testing plus periodic on-site inspections of
those LAPSA-accredited laboratories was transferred to the U.S. HHS,
with the HHS' NLCP contractor continuing to have an active role in
the performance testing and laboratory inspection processes. Other
Canadian laboratories wishing to be considered for the NLCP may
apply directly to the NLCP contractor just as U.S. laboratories do.
Upon finding a Canadian laboratory to be qualified, HHS will
recommend that DOT certify the laboratory (Federal Register, July
16, 1996) as meeting the minimum standards of the Mandatory
Guidelines published in the Federal Register on April 13, 2004 (69
FR 19644). After receiving DOT certification, the laboratory will be
included in the monthly list of HHS-certified laboratories and
participate in the NLCP certification maintenance program.
Anna Marsh,
Director, Office Program Services, SAMHSA.
[FR Doc. 05-20488 Filed 10-11-05; 8:45 am]
BILLING CODE 4160-20-U
